Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

NCT02598596 is registered in ClinicalTrials.gov with Ampel BioSolutions, LLC as lead sponsor.

NCT NCT02598596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02598596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
Lead sponsor
Ampel BioSolutions, LLC
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2015
Completion date
April 27, 2020
Enrollment
132 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

gout